Overview

GCC 0845:Vorinostat and Lapatinib in Advanced Solid Tumors and Advanced Breast Cancer to Evaluate Response and Biomarkers

Status:
Terminated
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
This research is being done to find out how safe and how well the combination of lapatinib and vorinostat works against advanced cancers.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
University of Maryland
University of Maryland, Baltimore
Collaborator:
University of Maryland Greenebaum Cancer Center
Treatments:
Lapatinib
Vorinostat